Piotr Byrski, as the CEO and Co-Founder of Molecule.one, is making strides in the pharmaceutical manufacturing sector by enhancing the predictability of chemical processes. His company strives to streamline the synthesis planning process for new molecules, facilitating the work of chemists and researchers. Byrski's leadership and vision are pivotal in pushing the boundaries of traditional chemistr...